Drug delivery strategies for combination ophthalmic treatments

Retina

Volumn 29, Issue SUPPL. 6, 2009, Pages

  Kuppermann, Baruch D ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Combination therapy; Drug delivery; Retinal pharmacotherapeutics

Indexed keywords

BEVACIZUMAB; GANCICLOVIR;

ANATOMY; CHRONIC DISEASE; DRUG ADMINISTRATION ROUTE; DRUG DELIVERY SYSTEM; DRUG DOSE REDUCTION; DRUG SAFETY; EYE; HUMAN; IMPLANT; NOTE; PATHOPHYSIOLOGY; RETINA MACULA AGE RELATED DEGENERATION; SUBRETINAL NEOVASCULARIZATION; TOXICITY; TREATMENT OUTCOME;

AGED; BLOOD-RETINAL BARRIER; DRUG DELIVERY SYSTEMS; DRUG IMPLANTS; DRUG THERAPY; DRUG THERAPY, COMBINATION; HUMANS; INJECTIONS; MACULAR DEGENERATION; OPHTHALMIC SOLUTIONS; RETINA; VITREOUS BODY;

EID: 68049147292     PISSN: 0275004X     EISSN: None     Source Type: Journal    
DOI: 10.1097/IAE.0b013e3181ad2463     Document Type: Note

References (1)

1. Hughes PM, Olejnik O, Chang-Lin JE, Wilson CG. Topical and systemic drug delivery to the posterior segments. Adv Drug Deliv Rev 2005;57:2010-2032. (Pubitemid 41740793)